Pure Global
NCT06324227

Effects of Multimodal Music Intervention on Mild Cognitive Impairment Elderly

Effects of Multimodal Music Intervention on Cognitive Function, Physical Fitness and Psychology of the Community Dwelling Elderly With Mild Cognitive Impairment
National Yang Ming University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mild Cognitive Impairment
Drug/Device/Intervention
multimodal music therapy
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
National Yang Ming University
Location
Taipei, Taiwan
Timeline & enrollment
Phase
N/A
Start date
Sep 17, 2023
End date
May 26, 2024
Enrollment
50 participants
Primary outcome

Montreal Cognitive Assessment,Saint Louis University Mental Status,Trail Making Test

Summary

The goal of this clinical trial is to learn about whether music therapy can ameliorate
 cognitive function, physical fitness and psychology in mild cognitive impairment and mild
 dementia population. The main questions it aims to answer are:
 
 1. To build a model of multimodal music therapy.
 
 2. To discuss the effect of twelve-week multimodal music therapy in ameliorating
 community-based elders with MCI and mild dementia. Main outcome variables: cognitive
 function (Montreal Cognitive Assessment Scale, trail making test, Saint Louis University
 Mental Status Examination). Secondary outcome variables: physical fitness (muscle
 strength, muscular endurance, flexibility, balance ability), depression.

ICD-10 classifications
Mild cognitive disorderAlzheimer diseaseDementia in other specified diseases classified elsewhereDementia in other diseases classified elsewhereDementia in Alzheimer disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06324227
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06324227 through Pure Global AI's free database. This phase not specified trial is sponsored by National Yang Ming University and is currently Recruiting. The study focuses on Mild Cognitive Impairment. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.